Stockreport

Investors in BridgeBio Pharma (NASDAQ:BBIO) have unfortunately lost 49% over the last three years [Yahoo! Finance]

BridgeBio Pharma, Inc.  (BBIO) 
Last bridgebio pharma, inc. earnings: 3/2 08:29 am Check Earnings Report
PDF BridgeBio Pharma, Inc. NASDAQ:BBIO ) shareholders, since the share price is down 49% in the last three years, falling well short of the market return of around 22%. W [Read more]